We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$87.2B
AUM Growth
-$982M
Cap. Flow
-$1.89B
Cap. Flow %
-2.16%
Top 10 Hldgs %
17.52%
Holding
2,206
New
298
Increased
599
Reduced
739
Closed
319

Top Buys

Rank Stock Value
1
J icon
Jacobs Solutions
J
+$291M
2
HSY icon
Hershey
HSY
+$278M
3
CVX icon
Chevron
CVX
+$274M
4
APD icon
Air Products & Chemicals
APD
+$268M
5
SAP icon
SAP
SAP
+$240M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$347M
2
DG icon
Dollar General
DG
+$290M
3
WDAY icon
Workday
WDAY
+$225M
4
PINS icon
Pinterest
PINS
+$165M
5
INTU icon
Intuit
INTU
+$150M

Sector Composition

Rank Sector Weight
1 Technology 27.47%
2 Healthcare 12.88%
3 Financials 11.68%
4 Industrials 10.33%
5 Consumer Discretionary 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VXUS icon
1751
Vanguard Total International Stock ETF
VXUS
$153B
$1.99K ﹤0.01%
33
-26
-44% -$1.57K
VOR icon
1752
Vor Biopharma
VOR
$1.04B
$1.95K ﹤0.01%
+97
New +$3.14K
TMP icon
1753
Tompkins Financial
TMP
$1.45B
$1.91K ﹤0.01%
+39
New +$1.8K
VOXX
1754
DELISTED
VOXX International Corporation Class A
VOXX
$1.91K ﹤0.01%
+603
New +$3.21K
GNLX icon
1755
Genelux
GNLX
$130M
$1.9K ﹤0.01%
+973
New +$3.31K
SEI
1756
Solaris Energy Infrastructure
SEI
$3.31B
$1.88K ﹤0.01%
+219
New +$1.92K
MODV
1757
DELISTED
ModivCare
MODV
$1.86K ﹤0.01%
+71
New +$1.8K
KLRS
1758
Kalaris Therapeutics
KLRS
$88.7M
$1.85K ﹤0.01%
+111
New +$1.96K
IXHL icon
1759
Incannex Healthcare
IXHL
$35.3M
$1.76K ﹤0.01%
20
TK icon
1760
Teekay
TK
$975M
$1.73K ﹤0.01%
+193
New +$1.63K
ELA icon
1761
Envela
ELA
$536M
$1.71K ﹤0.01%
+381
New +$1.74K
CMBM
1762
DELISTED
Cambium Networks
CMBM
$1.69K ﹤0.01%
+607
New +$2.13K
ATRA icon
1763
Atara Biotherapeutics
ATRA
$71.2M
$1.68K ﹤0.01%
+197
New +$2.96K
TCBX icon
1764
Third Coast Bancshares
TCBX
$709M
$1.59K ﹤0.01%
+75
New +$1.5K
BFS
1765
Saul Centers
BFS
$875M
$1.56K ﹤0.01%
+43
New +$1.57K
ZYXI
1766
DELISTED
Zynex
ZYXI
$1.53K ﹤0.01%
+164
New +$1.75K
CCO icon
1767
Clear Channel Outdoor Holdings
CCO
$1.23B
$1.49K ﹤0.01%
+1,058
New +$1.56K
IMRX icon
1768
Immuneering
IMRX
$279M
$1.45K ﹤0.01%
+1,136
New +$1.87K
VERY
1769
DELISTED
Vericity, Inc. Common Stock
VERY
$1.43K ﹤0.01%
125
+64
+105% +$726
CUTR
1770
DELISTED
Cutera, Inc.
CUTR
$1.42K ﹤0.01%
+943
New +$1.9K
EVI icon
1771
EVI Industries
EVI
$180M
$1.42K ﹤0.01%
+75
New +$1.56K
TREE icon
1772
LendingTree
TREE
$544M
$1.41K ﹤0.01%
+34
New +$1.43K
BHIL
1773
DELISTED
Benson Hill, Inc.
BHIL
$1.35K ﹤0.01%
+254
New +$1.68K
BTAI icon
1774
BioXcel Therapeutics
BTAI
$26.2M
$1.35K ﹤0.01%
+66
New +$2.21K
FOA icon
1775
Finance of America Companies
FOA
$204M
$1.34K ﹤0.01%
+272
New +$1.66K

Similar funds

Macquarie Group's Q2 2024 Portfolio in Review

As of Q2 2024, Macquarie Group held 2,206 positions worth $87.2B, down 1.1% from $88.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Macquarie Group's Q2 2024 filing shows 298 new, 599 increased, 739 reduced and 319 closed positions. Its largest new stake was AppFolio: 251,518 shares worth $61.5M. The largest sale was American International, an estimated $347M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q2 2024 buy was AppFolio: 251,518 shares worth $61.5M.
  • Macquarie Group added most to Jacobs Solutions in Q2 2024, an estimated $291M increase.
  • Macquarie Group's biggest Q2 2024 reduction was American International, cutting an estimated $347M.
  • Macquarie Group fully exited Vanguard Russell 2000 ETF in Q2 2024, selling an estimated $110M.
  • Macquarie Group's ten largest holdings make up 18% of its $87.2B portfolio in Q2 2024.
  • Macquarie Group opened 298 new positions and closed 319 in Q2 2024.
  • Macquarie Group's portfolio value fell 1.1% quarter-over-quarter to $87.2B.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.